6tys

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (09:13, 9 October 2024) (edit) (undo)
 
(2 intermediate revisions not shown.)
Line 1: Line 1:
==A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection==
==A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection==
-
<StructureSection load='6tys' size='340' side='right'caption='[[6tys]], [[Resolution|resolution]] 3.50&Aring;' scene=''>
+
<SX load='6tys' size='340' side='right' viewer='molstar' caption='[[6tys]], [[Resolution|resolution]] 3.50&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[6tys]] is a 9 chain structure with sequence from [http://en.wikipedia.org/wiki/Lk3_transgenic_mice Lk3 transgenic mice] and [http://en.wikipedia.org/wiki/Nipav Nipav]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6TYS OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6TYS FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[6tys]] is a 9 chain structure with sequence from [https://en.wikipedia.org/wiki/Henipavirus_nipahense Henipavirus nipahense] and [https://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6TYS OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6TYS FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Electron Microscopy, [[Resolution|Resolution]] 3.5&#8491;</td></tr>
-
<tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">Igkv12-98 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=10090 LK3 transgenic mice])</td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=6tys FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6tys OCA], [http://pdbe.org/6tys PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=6tys RCSB], [http://www.ebi.ac.uk/pdbsum/6tys PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=6tys ProSAT]</span></td></tr>
+
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6tys FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6tys OCA], [https://pdbe.org/6tys PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6tys RCSB], [https://www.ebi.ac.uk/pdbsum/6tys PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6tys ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
-
[[http://www.uniprot.org/uniprot/FUS_NIPAV FUS_NIPAV]] Class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and plasma cell membrane fusion, the heptad repeat (HR) regions assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and plasma cell membranes. Directs fusion of viral and cellular membranes leading to delivery of the nucleocapsid into the cytoplasm. This fusion is pH independent and occurs directly at the outer cell membrane. The trimer of F1-F2 (F protein) probably interacts with HN at the virion surface. Upon HN binding to its cellular receptor, the hydrophobic fusion peptide is unmasked and interacts with the cellular membrane, inducing the fusion between cell and virion membranes. Later in infection, F proteins expressed at the plasma membrane of infected cells could mediate fusion with adjacent cells to form syncytia, a cytopathic effect that could lead to tissue necrosis (By similarity).
+
[https://www.uniprot.org/uniprot/FUS_NIPAV FUS_NIPAV] Class I viral fusion protein. Under the current model, the protein has at least 3 conformational states: pre-fusion native state, pre-hairpin intermediate state, and post-fusion hairpin state. During viral and plasma cell membrane fusion, the heptad repeat (HR) regions assume a trimer-of-hairpins structure, positioning the fusion peptide in close proximity to the C-terminal region of the ectodomain. The formation of this structure appears to drive apposition and subsequent fusion of viral and plasma cell membranes. Directs fusion of viral and cellular membranes leading to delivery of the nucleocapsid into the cytoplasm. This fusion is pH independent and occurs directly at the outer cell membrane. The trimer of F1-F2 (F protein) probably interacts with HN at the virion surface. Upon HN binding to its cellular receptor, the hydrophobic fusion peptide is unmasked and interacts with the cellular membrane, inducing the fusion between cell and virion membranes. Later in infection, F proteins expressed at the plasma membrane of infected cells could mediate fusion with adjacent cells to form syncytia, a cytopathic effect that could lead to tissue necrosis (By similarity).
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 19: Line 19:
</div>
</div>
<div class="pdbe-citations 6tys" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 6tys" style="background-color:#fffaf0;"></div>
 +
 +
==See Also==
 +
*[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]]
 +
*[[3D structures of non-human antibody|3D structures of non-human antibody]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
-
</StructureSection>
+
</SX>
 +
[[Category: Henipavirus nipahense]]
[[Category: Large Structures]]
[[Category: Large Structures]]
-
[[Category: Lk3 transgenic mice]]
+
[[Category: Mus musculus]]
-
[[Category: Nipav]]
+
[[Category: Broder CB]]
-
[[Category: Broder, C B]]
+
[[Category: Chan YP]]
-
[[Category: Chan, Y P]]
+
[[Category: Da Silva SC]]
-
[[Category: Dang, H V]]
+
[[Category: Dang HV]]
-
[[Category: Feng, Y R]]
+
[[Category: Feng YR]]
-
[[Category: Geisbert, T]]
+
[[Category: Geisbert T]]
-
[[Category: Mire, C E]]
+
[[Category: Mire CE]]
-
[[Category: Park, Y J]]
+
[[Category: Park YJ]]
-
[[Category: Rockx, B]]
+
[[Category: Rockx B]]
-
[[Category: Structural genomic]]
+
[[Category: Snijder J]]
-
[[Category: Silva, S C.Da]]
+
[[Category: Veesler D]]
-
[[Category: Snijder, J]]
+
[[Category: Vu B]]
-
[[Category: Veesler, D]]
+
[[Category: Yan L]]
-
[[Category: Vu, B]]
+
-
[[Category: Yan, L]]
+
-
[[Category: Antibody]]
+
-
[[Category: Fusion glycoprotein]]
+
-
[[Category: Hendra virus]]
+
-
[[Category: Henipavirus]]
+
-
[[Category: Nipah virus]]
+
-
[[Category: Ssgcid]]
+
-
[[Category: Viral protein-immune system complex]]
+

Current revision

A potent cross-neutralizing antibody targeting the fusion glycoprotein inhibits Nipah virus and Hendra virus infection

6tys, resolution 3.50Å

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools